179 related articles for article (PubMed ID: 33762358)
21. ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
Centenera MM; Scott JS; Machiels J; Nassar ZD; Miller DC; Zinonos I; Dehairs J; Burvenich IJG; Zadra G; Chetta PM; Bango C; Evergren E; Ryan NK; Gillis JL; Mah CY; Tieu T; Hanson AR; Carelli R; Bloch K; Panagopoulos V; Waelkens E; Derua R; Williams ED; Evdokiou A; Cifuentes-Rius A; Voelcker NH; Mills IG; Tilley WD; Scott AM; Loda M; Selth LA; Swinnen JV; Butler LM
Cancer Res; 2021 Apr; 81(7):1704-1718. PubMed ID: 33547161
[TBL] [Abstract][Full Text] [Related]
22. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
23. Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT.
Zhao Y; Cai C; Zhang M; Shi L; Wang J; Zhang H; Ma P; Li S
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2013-2023. PubMed ID: 33772606
[TBL] [Abstract][Full Text] [Related]
24. MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer.
Wang L; Xu M; Qin J; Lin SC; Lee HJ; Tsai SY; Tsai MJ
Oncotarget; 2016 Mar; 7(12):14673-83. PubMed ID: 26895100
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
[TBL] [Abstract][Full Text] [Related]
26. PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness.
Kaminski L; Torrino S; Dufies M; Djabari Z; Haider R; Roustan FR; Jaune E; Laurent K; Nottet N; Michiels JF; Gesson M; Rocchi S; Mazure NM; Durand M; Tanti JF; Ambrosetti D; Clavel S; Ben-Sahra I; Bost F
Cancer Res; 2019 Jul; 79(13):3268-3280. PubMed ID: 31064849
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S
PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245
[TBL] [Abstract][Full Text] [Related]
28. Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
Shi L; Yan Y; He Y; Yan B; Pan Y; Orme JJ; Zhang J; Xu W; Pang J; Huang H
Cancer Res; 2021 Jul; 81(13):3593-3606. PubMed ID: 33762355
[TBL] [Abstract][Full Text] [Related]
29. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
30. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
[TBL] [Abstract][Full Text] [Related]
31. Blockade of fructose transporter protein GLUT5 inhibits proliferation of colon cancer cells: proof of concept for a new class of anti-tumor therapeutics.
Włodarczyk J; Włodarczyk M; Zielińska M; Jędrzejczak B; Dziki Ł; Fichna J
Pharmacol Rep; 2021 Jun; 73(3):939-945. PubMed ID: 34052986
[TBL] [Abstract][Full Text] [Related]
32. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
[TBL] [Abstract][Full Text] [Related]
33. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
[TBL] [Abstract][Full Text] [Related]
34. HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.
Zhou X; Li Q; He J; Zhong L; Shu F; Xing R; Lv D; Lei B; Wan B; Yang Y; Wu H; Mao X; Zou Y
Oncotarget; 2017 Mar; 8(12):19342-19353. PubMed ID: 28038443
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
[TBL] [Abstract][Full Text] [Related]
36. Functional expression of sodium-glucose transporters in cancer.
Scafoglio C; Hirayama BA; Kepe V; Liu J; Ghezzi C; Satyamurthy N; Moatamed NA; Huang J; Koepsell H; Barrio JR; Wright EM
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4111-9. PubMed ID: 26170283
[TBL] [Abstract][Full Text] [Related]
37. Independence of HIF1a and androgen signaling pathways in prostate cancer.
Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
[TBL] [Abstract][Full Text] [Related]
38. Regulation of adipose differentiation by fructose and GluT5.
Du L; Heaney AP
Mol Endocrinol; 2012 Oct; 26(10):1773-82. PubMed ID: 22827929
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
Song Y; Song C; Yang S
Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]